The Financial Express

Johnson & Johnson quarterly sales rise 8.3pc, sees vaccine data "soon"

| Updated: January 28, 2021 10:49:01

Evaly and Fianancial Express Mobile Evaly and Fianancial Express Desktop
Johnson & Johnson quarterly sales rise 8.3pc

Johnson & Johnson on Tuesday posted an 8.3 per cent rise in quarterly sales and said it would share details from its keenly watched coronavirus vaccine trial soon, as the healthcare conglomerate races to develop a potential single-dose vaccine for COVID-19.

Quarterly sales rose to $22.48 billion from $20.75 billion.




Share if you like